Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martine Clozel

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Annals of Medicine|January 8, 2004
Effects of bosentan on cellular processes involved in pulmonary arterial hypertension: do they explain the long-term benefit?Martine Clozel
Science Translational Medicine|January 29, 2011
Between confidentiality and scientific exchange: the place of publication in drug discovery and pharmaceutical researchMartine Clozel
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|August 19, 2016
Endothelin research and the discovery of macitentan for the treatment of pulmonary arterial hypertensionMartine Clozel
Canadian Journal of Physiology and Pharmacology|March 4, 2022
Aprocitentan and the endothelin system in resistant hypertensionMartine Clozel
Annals of Medicine|May 21, 2005
Role of endothelin in fibrosis and anti-fibrotic potential of bosentanMartine Clozel, Hashem Salloukh
Clinical Science (London, England : 1979)|August 18, 2010
At the heart of tissue: endothelin system and end-organ damageMarc Iglarz, Martine Clozel
Journal of Cardiovascular Pharmacology|December 20, 2007
Mechanisms of ET-1-induced endothelial dysfunctionMarc Iglarz, Martine Clozel
Advances in Pharmacology (San Diego, Calif.)|November 18, 2010
The cardiovascular physiology and pharmacology of endothelin-1Eric Thorin, Martine Clozel
Handbook of Experimental Pharmacology|October 5, 2013
Endothelin receptor antagonistsMartine Clozel, Alessandro Maresta, Marc Humbert
Current Protocols in Pharmacology|February 2, 2012
Monocrotaline-induced pulmonary hypertension in Wistar ratsMarkus Rey, Patrick Hess, Martine Clozel
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Annals of Medicine|January 8, 2004
Effects of bosentan on cellular processes involved in pulmonary arterial hypertension: do they explain the long-term benefit?Martine Clozel
Science Translational Medicine|January 29, 2011
Between confidentiality and scientific exchange: the place of publication in drug discovery and pharmaceutical researchMartine Clozel
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|August 19, 2016
Endothelin research and the discovery of macitentan for the treatment of pulmonary arterial hypertensionMartine Clozel
Canadian Journal of Physiology and Pharmacology|March 4, 2022
Aprocitentan and the endothelin system in resistant hypertensionMartine Clozel
Annals of Medicine|May 21, 2005
Role of endothelin in fibrosis and anti-fibrotic potential of bosentanMartine Clozel, Hashem Salloukh
Clinical Science (London, England : 1979)|August 18, 2010
At the heart of tissue: endothelin system and end-organ damageMarc Iglarz, Martine Clozel
Journal of Cardiovascular Pharmacology|December 20, 2007
Mechanisms of ET-1-induced endothelial dysfunctionMarc Iglarz, Martine Clozel
Advances in Pharmacology (San Diego, Calif.)|November 18, 2010
The cardiovascular physiology and pharmacology of endothelin-1Eric Thorin, Martine Clozel
Handbook of Experimental Pharmacology|October 5, 2013
Endothelin receptor antagonistsMartine Clozel, Alessandro Maresta, Marc Humbert
Current Protocols in Pharmacology|February 2, 2012
Monocrotaline-induced pulmonary hypertension in Wistar ratsMarkus Rey, Patrick Hess, Martine Clozel
Pageof 6